The malaria burden in Bhutan decreased significantly during the study period with high coverage of long-lasting insecticidal nets. The foreseeable challenges that require national attention to maintain a malaria-free status after elimination are importation of malaria, especially from India; continued protection of the population in endemic districts through complete coverage with long-lasting insecticidal nets and indoor residual spraying; and exploration of local funding modalities post-elimination in the event of a reduction in international funding.
Background: Malaria is a vector-borne disease which, despite recent scaled-up efforts to achieve control in Africa, continues to pose a major threat to child survival.
Huffington Post: Overcoming Challenges in Global Health Mark Dybul, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria “…The fight against [HIV, TB, and malaria] is more important than ever in a world increasingly affected by natural disasters, conflict and economic crises. … This new reality is why the Global Fund has…More
Raquel Peck is the CEO of the World Hepatitis Alliance (WHA), she shares her hope that stronger action on viral hepatitis will be high on the agenda for the 69th World Health Assembly in Geneva (convening this week). Raquel’s piece is part of a series of articles Translational Global Health will run on WHA69. If you or your organisation have a particular focus at the Assembly you feel requires urgent attention, contact our Editor. We are at a turning point. This week, 194 countries will convene to decide the fate of millions of people living with viral hepatitis. At the 69th World Health Assembly in Geneva (23 – 28 May), governments will deliberate on the adoption of WHO’s first ever Global Health Sector Strategy for Viral Hepatitis (GHSS), which sets a goal of eliminating hepatitis B and C by 2030, two significant public health issues that can lead to cirrhosis, liver cancer and death.
WHO Director-General Dr Margaret Chan opened the Sixty-ninth World Health Assembly with words of celebration, warning, and hope. Dr Chan celebrated recent progress in global public health, particularly in combatting HIV, tuberculosis, malaria and polio, as well as in improving maternal and child health.
The present paper reports on studies that evaluated artesunate + sulfadoxine-pyrimethamine (AS + SP) which is the first-line drug and artemether-lumefantrine (AL) which is a second-line drug against uncomplica…
Village malaria workers (VMWs) and mobile malaria workers (MMWs) are a critical component of Cambodia’s national strategy to eliminate Plasmodium falciparum malaria by 2025.
The success of malaria vector control is threatened by widespread pyrethroid insecticide resistance.
In Tanzania there has been a downward trend in malaria prevalence partly due to use of insecticide-treated bed nets for protection against Anopheles mosquitoes.
In the Tanzanian city of Dar es Salaam, high coverage of long-lasting insecticidal nets (LLINs), larvicide application (LA) and mosquito-proofed housing, was complemented with improved access to artemisinin-ba…
In 2012 the Artemisinin Monotherapy Therapy Replacement (AMTR) project was implemented in Eastern Myanmar to increase access to subsidized, quality-assured artemisinin combination therapy (ACT) and to remove o…
Brazil currently contributes 42 % of all malaria cases reported in the Latin America and the Caribbean, a region where major progress towards malaria elimination has been achieved in recent years.
The Economist: When the drugs don’t work “…Resistance to antimicrobial medicines, such as antibiotics and antimalarials, is caused by the survival of the fittest. Unfortunately, fit microbes mean unfit human beings. … Combining policies to accomplish many things at once demands political leadership, but recent global campaigns against HIV/AIDS and malaria show that it is…More
Knowledge about feeding preference of blood-sucking insects is important for the better understanding epidemiology of vector-borne parasitic diseases.
The search for a vaccine against malaria caused by Plasmodium falciparum has lasted for more than 100 years, with considerable progress in the identification of a number of vaccine candidates.